Thomas H. Kean, Jr. Stock Trades

Thomas H. Kean, Jr.

Since January 2023, Representative Thomas H. Kean, Jr., the New Jersey Republican who represents the state's 7th District, has filed reports containing 178 disclosed securities transactions under the Stop Trading on Congressional Knowledge Act. That activity sets him apart in a Congress where disclosed trading is far from universal: an August 22, 2026 population snapshot counts 276 members with no disclosed trades among the 537 sitting members of Congress, including 237 of the House's 437 members. Kean is not one of them. The annual transaction count rose from 30 in 2023 to 35 in 2024 and 59 in 2025; the 2026 record contains 54 transactions through the most recent filing.

The composition of that activity has shifted year to year. In 2023, sales outnumbered purchases 14 to 9, with 7 transactions categorized as other rounding out the year. That reversed in 2024, when purchases led 17 to 5, and again in 2025, when purchases outpaced sales 34 to 22. In 2026, the pattern flipped back toward selling, with 33 sales against 21 purchases through the most recent disclosures. Of all 178 transactions, 177 carry a “Self” attribution and one carries a spousal attribution. The disclosures therefore attribute nearly all of the activity to Kean, with one spouse-attributed exception; the “Self” code identifies the filer relationship but does not establish who selected or executed a transaction.

Sector Concentration and Frequently Disclosed Names

Health care is the dominant theme in Kean's disclosures, accounting for 37 of the transactions tallied by sector, ahead of financials at 28, an unclassified “Unknown” bucket at 24, industrials at 22, information technology at 18, communication services at 16, consumer discretionary at 12, materials at 11, energy at 3, real estate at 3, consumer staples at 2, and a separately tracked “technology” category at 2.

Stryker Corporation, the Michigan-based medical technology company known for surgical equipment, orthopedic implants and its Mako robotic-assisted surgery products, is the single most frequently disclosed security, appearing in 12 transactions, every one of them a sale. Johnson & Johnson, the New Brunswick, New Jersey pharmaceutical and medical technology company, follows with 8 transactions, also all sales. That pairing, one Michigan medical-technology company and one based in Kean's home state, forms one of the clearer patterns in the filings: both securities appear repeatedly in sales, with no disclosed purchases in the transaction record.

Financials tell a more mixed story. Markel Corporation and S&P Global appear in 5 and 4 transactions respectively, all sales. First Citizens BancShares appears in 5 transactions split between 3 purchases and 2 sales, making it a name for which the record contains both transaction types. Amazon.com stands out on the buy side: all 5 of its disclosed transactions are purchases, with no Amazon sales in the record. Analog Devices, Check Point Software Technologies and nVent Electric each show a mix of purchases and sales across 4 transactions apiece, while Alphabet's Class A shares and Microsoft appear 4 times each, weighted toward sales in both cases. Two other securities disclosed three times each are worth noting for their one-directional transaction records: ESAB Corporation, the welding and cutting-equipment manufacturer, and EQT Corporation, the Appalachian natural gas producer, each show 3 purchases and no sales. The latest transaction date supplied for both is July 7, 2026.

The Latest Disclosures and What the Companies Do

Kean's most recent filing, dated August 18, 2026, reports self-attributed transactions executed from July 7 through July 22, 2026, and continues several of the patterns above. It reports partial sales of Stryker and Alphabet's Class A shares on July 22. For July 8, it reports purchases of Amazon.com and Toast, Inc., the Boston-based restaurant-technology company whose cloud platform handles point-of-sale, payments and back-office operations for restaurants. It also reports purchases of ESAB and EQT on July 7, giving each security a third disclosed purchase and no sales in the record. Each transaction in this filing carries a disclosed amount range of $1,001 to $15,000.

The filing immediately prior, dated July 15, 2026, includes transactions executed from June 1 through June 30. Among its late-June entries are partial sales of Analog Devices, Johnson & Johnson, Markel and S&P Global, two purchases of ESAB, a partial sale of Alphabet and a purchase of a U.S. Treasury Note. Treasury Note purchases recur elsewhere in the transaction history on October 17 and December 31, 2025, twice on February 18, 2026, and again on May 4 and June 17, 2026. The disclosures identify those instruments as government securities, distinguishing them from the stock transactions reported alongside them.

Further back, the record shows repeated purchase-only activity in names like Amcor, the Zurich-based packaging manufacturer; Canadian Pacific Kansas City, the freight railway; and Danaher, the diagnostics and life-sciences instruments company. Each appears in multiple purchases without a sale in the disclosed transaction data. On the sale side, Franklin Resources, the asset manager, and Oracle each show more sales than purchases across their disclosed transactions. A filing dated January 16, 2026, also reports exchange transactions executed on December 16, 2025, in Liberty Live Holdings' Series A and Series C shares. Liberty Live is described in the data as a live-entertainment company, and an exchange is categorized separately from an outright purchase or sale.

Against this disclosure record, Quantellect's scoring model, last updated August 21, 2026, rates Kean's disclosed activity 79 out of 100, placing him in the “solid” tier and ranking him 17th in a 76-member scoring cohort.

Disclosure Notes and Attribution

This profile is built from Kean's official Periodic Transaction Reports filed with the Clerk of the House, as required under the Stop Trading on Congressional Knowledge Act of 2012. Members of Congress must disclose transactions in stocks, bonds and other securities within specific reporting windows; the House Committee on Ethics' financial disclosure instruction guide sets out the reporting rules, including the amount ranges rather than exact dollar figures used throughout these filings and the codes used to attribute a transaction to the member, a spouse or a dependent.

Of the 178 transactions in this record, 177 carry a “Self” attribution and one carries a spousal attribution; none are attributed as joint, attributed to a dependent child, or left unattributed. Dollar amounts throughout are disclosed ranges, not exact figures, under the reporting rules. The securities discussed above are included solely because they appear in transaction-level disclosures, which record purchases, sales, exchanges and other reportable events rather than providing a complete inventory of assets.